Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Employment/Membership › Details

Clade Therapeutics–Vasella D: board, 202111 Board Chairman formerly CEO of Novartis

 

Period Period 2021-11-03
Organisations Organisation Clade Therapeutics Inc.
  Organisation 2 Novartis AG (NYSE: NVS)
  Group Novartis (Group)
Products Product iPSC technology (induced pluripotent stem cell technology)
  Product 2 pharmaceutical
Person Person Vasella, Daniel (Novartis CEO 199612–201001 after 1/10 continues as Chairman)
     

   
Record changed: 2021-11-13

Advertisement

Picture [iito] Fighting Customers 650x100px

More documents for Clade Therapeutics Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Voices from Berlin-Brandenburg 650x80px




» top